Short-Term Performance Is Raring for an Outclass: Susquehanna  Susquehanna analyst Christopher Rolland is so confident on Advanced Micro Devices, Inc. (NASDAQ:AMD) ahead of the chip giant’s …

A heavy-hitter catalyst is about to go up to bat for AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a key FDA decision looming in the foreground, …

Helios and Matheson Analytics Inc (NASDAQ:HMNY) investors are deciding they want to play with fire, or at least that is how infamous short-seller …

Everyone knows that being out of work is terrible. The financial and, consequently, personal impact of being without a job reaches farther than …

Cowen sees hope for ECYT amid acquisition refocus; H.C.

There’s more than meets the eye when it comes to Veritone, says Brian Alger in response to Citron’s comments.

Genocea shares are plunging on termination of genital herpes treatment GEN-003.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …

According to leading financial authorities, the economy of the United Kingdom is in dire shape. If UBS is correct, then economic stagnation faces …

Edward Nash Sees Otonomy as a Pure Speculative Pharma Play